Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03868085 · ClinicalTrials.gov registry record
The Natural History of Injury-Related Disuse Osteopenia
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 51
- Enrollment target
NCT03868085: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT03868085 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03868085 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
Determine the severity and time course (natural history) of disuse osteopenia that occurs in the lower extremity(ies) and lumbar spine of patients sustaining lower extremity injuries that require the patient to maintain restricted weight bearing status (12 weeks) following the surgical fixation of the patient's injuries. The investigators hypothesize that there will be a significant decrease in the bone mineral density in the lower limbs of patients undergoing restricted weight bearing for peri-articular injuries of the lower extremity. This loss of bone mineral density is often prolonged in its duration and may lower subsequent fracture threshold and prolong the time to recovery and return to activities.
Primary Outcome
Hip bone mineral density (DXA) of control and injured limb will be measured following weight bearing restrictions as part of treatment of lower limb articular injury and again following resumption of weight bearing after healing of the injury.
Interventions
- DIAGNOSTIC_TEST dual energy x-ray absorptiometry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2017-05-31 |
| Est. Completion | 2020-12-10 |
What the finished NCT03868085 record still lists
NCT03868085 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which dual energy x-ray absorptiometry is the first listed.
NCT03868085 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03868085 about?
NCT03868085 is a clinical study titled "The Natural History of Injury-Related Disuse Osteopenia". Determine the severity and time course (natural history) of disuse osteopenia that occurs in the lower extremity(ies) and lumbar spine of patients sustaining lower extremity injuries that require the patient to maintain restricted weight bearing status (12 weeks) following the surgical fixation of t...
What is the current status of trial NCT03868085?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2017-05-31. Estimated completion is 2020-12-10.
What interventions are being tested in trial NCT03868085?
The interventions under investigation include: dual energy x-ray absorptiometry (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03868085?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI